Anna-Mari Hokkanen

Helsinki University Hospital

Finland

Research Interests

Explore related searches

Professors in Finland Professors in Immunology Immunology professors in Finland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Collaborators (9)

Jakub Závada

Institute of Rheumatology

CZECH REPUBLIC

View details

Anne Gitte Loft

Aarhus University

DENMARK

View details

Gareth Jones

University of Aberdeen

UNITED KINGDOM

View details

Daniela Di Giuseppe

Karolinska University Hospital

SWEDEN

View details

Ronald van Vollenhoven

Professor and Chief

Amsterdam UMC

NETHERLANDS

View details

Rosemary Hollick

University of Aberdeen

UNITED KINGDOM

View details

Anabela Barcelos

Centro Hospitalar do Baixo Vouga EPE

PORTUGAL

View details

Ulf Lindström

University of Gothenburg

SWEDEN

View details

Lucía Otero Varela

Profesora

Universidad CEU San Pablo

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna-Mari Hokkanen

Research Interests

Explore related searches

Contact this professor

Articles (10)

Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis

Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis

Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors

Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis

Impact of TNF inhibitor medication on working ability in axial spondyloarthritis: an observational national registry-based cohort study

One‐Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses

Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment

Collaborators (9)

Jakub Závada

Anne Gitte Loft

Gareth Jones

Daniela Di Giuseppe

Ronald van Vollenhoven

Rosemary Hollick

Anabela Barcelos

Ulf Lindström

Lucía Otero Varela

Make your next move.